Mariana Verdelho Machado

Prediction of Response to Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?

Worldwide, liver cancer is the seventh most common cancer and the third leading cause of cancer-related mortality, reflecting its dismal prognosis, with only approximately 20% of patients alive 5 years after diagnosis. At least 50% of patients ultimately require systemic treatment. In 2020, the systemic treatment lands...